Your browser doesn't support javascript.
loading
Reporter nanoparticle that monitors its anticancer efficacy in real time.
Kulkarni, Ashish; Rao, Poornima; Natarajan, Siva; Goldman, Aaron; Sabbisetti, Venkata S; Khater, Yashika; Korimerla, Navya; Chandrasekar, Vineethkrishna; Mashelkar, Raghunath A; Sengupta, Shiladitya.
Afiliação
  • Kulkarni A; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115; ashishk@mit.edu ram@ncl.res.in shiladit@mit.edu.
  • Rao P; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Natarajan S; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Goldman A; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Sabbisetti VS; Division of Renal (Kidney) Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
  • Khater Y; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Korimerla N; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Chandrasekar V; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115;
  • Mashelkar RA; National Chemical Laboratory, Pune 411008, India; ashishk@mit.edu ram@ncl.res.in shiladit@mit.edu.
  • Sengupta S; Laboratory of Nanomedicine, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115; Division of Biomedical Engineering, Harvard Medical School, Boston, MA 02115; Dana Farber Cancer Institute, Boston, MA 02115 ashishk@mit.edu
Proc Natl Acad Sci U S A ; 113(15): E2104-13, 2016 Apr 12.
Article em En | MEDLINE | ID: mdl-27036008
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Monitorização Imunológica / Monitoramento de Medicamentos / Nanopartículas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Monitorização Imunológica / Monitoramento de Medicamentos / Nanopartículas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article